DOMH Company Profile and Key Details
Dominari Holdings Inc.
DOMH Stock Price Chart
Stock Price Today
Dominari Holdings Inc. (DOMH) stock surged +89.23%, trading at $13.00 on NASDAQ, up from the previous close of $6.87. The stock opened at $8.29, fluctuating between $7.68 and $13.49 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.
Company Information
| Employees | 26 |
| Beta | 0.96 |
| Sales or Revenue | $2.04M |
| 5Y Sales Change% | 0.553% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Dominari Holdings Inc. (NASDAQ: DOMH) stock price is $13.00 in the last trading session. During the trading session, DOMH stock reached the peak price of $13.49 while $7.68 was the lowest point it dropped to. The percentage change in DOMH stock occurred in the recent session was 89.23% while the dollar amount for the price change in DOMH stock was $6.13.
The NASDAQ listed DOMH is part of Biotechnology industry that operates in the broader Healthcare sector. Dominari Holdings Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Matthew B. McCullough
Gen. Counsel
Mr. Christopher Devall
Chief Operating Officer
Mr. Anthony C. Hayes Esq.
Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer & Director
Mr. George Michael Way C.P.A., CPA
Chief Financial Officer
Mr. Darrell Dotson
Vice President of Drug Devel. & Gen. Counsel
Mr. Carlos Aldavero
Pres of Dominari Financial Inc.
Mr. George Michael Way CPA, CPA
Chief Financial Officer
DOMH's closing price is 1,466.27% higher than its 52-week low of $0.83 where as its distance from 52-week high of $13.49 is -3.63%.
Number of DOMH employees currently stands at 26.
Official Website of DOMH is: https://www.aikidopharma.com
DOMH could be contacted at phone 703 992 9325 and can also be accessed through its website. DOMH operates from One Rockefeller Plaza, New York, NY 10020, United States.
DOMH stock volume for the day was 10.5M shares. The average number of DOMH shares traded daily for last 3 months was 1.16M.
The market value of DOMH currently stands at $82.37M with its latest stock price at $13.00 and 6.34M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com